{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:21:47Z","timestamp":1793924507038,"version":"4.8.0"},"reference-count":129,"publisher":"Bentham Science Publishers Ltd.","issue":"26","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>COVID-19 disrupted NTD programs in 60% of countries, impairing\npublic health goals. Thus, boosting NTD's research knowledge is demanding, and\nin vivo screening of candidates allows for the prospect of promising options based on their\noverall profile.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>In this work, we highlighted the relevant research done between 2015-2021 in\nthe fields of synthetic and repurposed drugs that were tested in vivo for Chagas disease,\nmalaria, and schistosomiasis.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>MEDLINE, PUBMED, CAPES PERIODIC, and ELSEVIER databases were used\nfor a comprehensive literature review of the last 6 years of research on each area\/disease.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Overall, research focused on nitro heterocyclic, aromatic nitro, nucleoside, and\nmetal-based scaffolds for analogue-based drug generation. Repurposing was widely assessed,\nmainly with heterocyclic drugs, their analogues, and in combinations with current\ntreatments. Several drug targets were aimed for Chagas treatment, specific ones such as iron\nsuperoxide dismutase, and more general ones, such as mitochondrial dysfunction. For malaria,\nhemozoin is still popular, and for schistosomiasis, more general structural damage and\/or\nreproduction impairment were aimed at in vitro analysis of the mechanism of action.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Latest in vivo results outlined trends for each disease - for Chagas Disease,\nheterocyclics as thiazoles were successfully explored; for Malaria, quinoline derivatives\nare still relevant, and for schistosomiasis, repurposed drugs from different classes outstood\nin comparison to synthetic compounds. This study uprises the continuous development\nof Chagas disease, malaria, and schistosomiasis drugs, providing researchers with\ntools and information to address such unmet therapeutic needs.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867329666220930112136","type":"journal-article","created":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T15:28:52Z","timestamp":1664551732000},"page":"2932-2976","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Outlining the Molecules Tested <i>In Vivo<\/i> for Chagas Disease, Malaria,\nand Schistosomiasis Over the Last Six Years - A Literature Review\nFocused on New Synthetic Drug Identities and Repurposing Strategies"],"prefix":"10.2174","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3610-5790","authenticated-orcid":true,"given":"Vanessa Gouveia","family":"de Melo Silva","sequence":"first","affiliation":[{"name":"Departamento de Ci\u00eancias Farmac\u00eauticas, Centro de Ci\u00eancias da Sa\u00fade, Universidade Federal de Pernambuco,\n50740-520, Recife, PE, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8596-1905","authenticated-orcid":true,"given":"Juliana Maria","family":"da Concei\u00e7\u00e3o","sequence":"additional","affiliation":[{"name":"Departamento de Ci\u00eancias Farmac\u00eauticas, Centro de Ci\u00eancias da Sa\u00fade, Universidade Federal de Pernambuco,\n50740-520, Recife, PE, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0428-9417","authenticated-orcid":true,"given":"Carla Cauanny","family":"Vieira Costa Silva","sequence":"additional","affiliation":[{"name":"Departamento de Ci\u00eancias Farmac\u00eauticas, Centro de Ci\u00eancias da Sa\u00fade, Universidade Federal de Pernambuco,\n50740-520, Recife, PE, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5368-3998","authenticated-orcid":true,"given":"Amanda Calazans","family":"Leal","sequence":"additional","affiliation":[{"name":"Departamento de Ci\u00eancias Farmac\u00eauticas, Centro de Ci\u00eancias da Sa\u00fade, Universidade Federal de Pernambuco,\n50740-520, Recife, PE, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1625-0368","authenticated-orcid":true,"given":"Daniel Lopes","family":"Ara\u00fajo","sequence":"additional","affiliation":[{"name":"Departamento de Ci\u00eancias Farmac\u00eauticas, Centro de Ci\u00eancias da Sa\u00fade, Universidade Federal de Pernambuco,\n50740-520, Recife, PE, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0759-8335","authenticated-orcid":true,"given":"Janine Siqueira","family":"Nunes","sequence":"additional","affiliation":[{"name":"Departamento de Ci\u00eancias Farmac\u00eauticas, Centro de Ci\u00eancias da Sa\u00fade, Universidade Federal de Pernambuco,\n50740-520, Recife, PE, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2128-807X","authenticated-orcid":true,"given":"Elineide Tayse Noberto","family":"da Silva","sequence":"additional","affiliation":[{"name":"Departamento de Ci\u00eancias Farmac\u00eauticas, Centro de Ci\u00eancias da Sa\u00fade, Universidade Federal de Pernambuco,\n50740-520, Recife, PE, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5563-165X","authenticated-orcid":true,"given":"Anderson Jos\u00e9 Firmino Santos","family":"da Silva","sequence":"additional","affiliation":[{"name":"Departamento de Ci\u00eancias Farmac\u00eauticas, Centro de Ci\u00eancias da Sa\u00fade, Universidade Federal de Pernambuco,\n50740-520, Recife, PE, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6499-2385","authenticated-orcid":true,"given":"Mabilly Cox Holanda","family":"de Barros Dias","sequence":"additional","affiliation":[{"name":"Departamento de Ci\u00eancias Farmac\u00eauticas, Centro de Ci\u00eancias da Sa\u00fade, Universidade Federal de Pernambuco,\n50740-520, Recife, PE, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9346-2292","authenticated-orcid":true,"given":"Ana Cristina","family":"Lima Leite","sequence":"additional","affiliation":[{"name":"Departamento de Ci\u00eancias Farmac\u00eauticas, Centro de Ci\u00eancias da Sa\u00fade, Universidade Federal de Pernambuco,\n50740-520, Recife, PE, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","unstructured":"World Health Organization (WHO). Global health estimates 2015: Disease burden by cause, age, sex, by country and by region, 2000\u20132015. 2015. Available from:  (Accessed on: 12 July 2021)."},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41586-018-0327-4","volume":"559","author":"De Rycker M.","year":"2018","unstructured":"De Rycker M.; Baraga\u00f1a B.; Duce S.L.; Gilbert I.H.; Challenges and recent progress in drug discovery for tropical diseases. Nature 2018,559(7715),498-506","journal-title":"Nature"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3390\/md16080279","volume":"16","author":"Lage O.","year":"2018","unstructured":"Lage O.; Ramos M.; Calisto R.; Almeida E.; Vasconcelos V.; Vicente F.; Current screening methodologies in drug discovery for selected human diseases. Mar Drugs 2018,16(8),279","journal-title":"Mar Drugs"},{"key":"ref=4","unstructured":"World Health Organization (WHO). Neglected tropical diseases: Preventive chemotherapy treatment coverage declines due to COVID-19 disruptions. 2020. Available from:  (accessed on: 12 July 2021)."},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"717","DOI":"10.3389\/fmicb.2017.00717","volume":"8","author":"Zhan L.","year":"2017","unstructured":"Zhan L.; Tang J.; Sun M.; Qin C.; Animal models for tuberculosis in translational and precision medicine. Front Microbiol 2017,8,717","journal-title":"Front Microbiol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00281-015-0538-9","volume":"38","author":"Kramnik I.","year":"2016","unstructured":"Kramnik I.; Beamer G.; Mouse models of human TB pathology: Roles in the analysis of necrosis and the development of host-directed therapies. Semin Immunopathol 2016,38(2),221-237","journal-title":"Semin Immunopathol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"e2252","DOI":"10.1371\/journal.pone.0002252","volume":"3","author":"Angulo-Barturen I.","year":"2008","unstructured":"Angulo-Barturen I.; Jim\u00e9nez-D\u00edaz M.B.; Mulet T.; Rullas J.; Herreros E.; Ferrer S.; Jim\u00e9nez E.; Mendoza A.; Regadera J.; Rosenthal P.J.; Bathurst I.; Pompliano D.L.; G\u00f3mez de las Heras F.; Gargallo-Viola D.; A murine model of falciparum-malaria by in vivo selection of competent strains in non-myelodepleted mice engrafted with human erythrocytes. PLoS One 2008,3(5),e2252","journal-title":"PLoS One"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.chom.2015.02.011","volume":"17","author":"Mikolajczak S.A.","year":"2015","unstructured":"Mikolajczak S.A.; Vaughan A.M.; Kangwanrangsan N.; Roobsoong W.; Fishbaugher M.; Yimamnuaychok N.; Rezakhani N.; Lakshmanan V.; Singh N.; Kaushansky A.; Camargo N.; Baldwin M.; Lindner S.E.; Adams J.H.; Sattabongkot J.; Kappe S.H.I.; Plasmodium vivax liver stage development and hypnozoite persistence in human liver-chimeric mice. Cell Host Microbe 2015,17(4),526-535","journal-title":"Cell Host Microbe"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.2174\/156802661815181101110430","volume":"18","author":"Dea-Ayuela M.A.","year":"2018","unstructured":"Dea-Ayuela M.A.; Serrano D.R.; New drugs and therapeutic\/diagnostic targets for fungal and parasitic diseases - Part I. Curr Top Med Chem 2018,18(15),1274","journal-title":"Curr Top Med Chem"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"4226","DOI":"10.2174\/0929867327999201116145408","volume":"28","author":"de Barros Dias M.C.H.","year":"2021","unstructured":"de Barros Dias M.C.H.; Freitas L.A.B.; dos Santos I.R.; de Almeida V.S.; do Amaral e Melo, R.T.; de Melo Silva, V.G.; de F\u00e1tima Maia de Santana, B.; da Concei\u00e7\u00e3o, J.M.; Lima Leite, A.C. An overview of the compounds tested in vivo for Leishmania spp. of the Last 5 years. Curr Med Chem 2021,28(21),4226-4258","journal-title":"Curr Med Chem"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"eaat0805","DOI":"10.1126\/science.aat0805","volume":"363","author":"Campos K.R.","year":"2019","unstructured":"Campos K.R.; Coleman P.J.; Alvarez J.C.; Dreher S.D.; Garbaccio R.M.; Terrett N.K.; Tillyer R.D.; Truppo M.D.; Parmee E.R.; The importance of synthetic chemistry in the pharmaceutical industry. Science 2019,363(6424),eaat0805","journal-title":"Science"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"6480","DOI":"10.1021\/acs.jmedchem.7b00010","volume":"60","author":"Flick A.C.","year":"2017","unstructured":"Flick A.C.; Ding H.X.; Leverett C.A.; Kyne R.E.; Liu K.K-C.; Fink S.J.; O\u2019Donnell C.J.; Synthetic approaches to the new drugs approved during 2015. J Med Chem 2017,60(15),6480-6515","journal-title":"J Med Chem"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrd1468","volume":"3","author":"Ashburn T.T.","year":"2004","unstructured":"Ashburn T.T.; Thor K.B.; Drug repositioning: Identifying and developing new uses for existing drugs. Nat Rev Drug Discov 2004,3(8),673-683","journal-title":"Nat Rev Drug Discov"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrd.2018.92","volume":"18","author":"Breckenridge A.","year":"2019","unstructured":"Breckenridge A.; Jacob R.; Overcoming the legal and regulatory barriers to drug repurposing. Nat Rev Drug Discov 2019,18(1),1-2","journal-title":"Nat Rev Drug Discov"},{"key":"ref=15","unstructured":"World Health Organization. WHO calls for comprehensive, equitable access to healthcare for every CD patient. Departmental news, Geneva. Available from:  (Accessed on: July 12, 2021)."},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/S0140-6736(17)31612-4","volume":"391","author":"P\u00e9rez-Molina J.A.","year":"2018","unstructured":"P\u00e9rez-Molina J.A.; Molina I.; Chagas disease. Lancet 2018,391(10115),82-94","journal-title":"Lancet"},{"key":"ref=17","unstructured":"Medscape. BZN (Rx), Drugs and diseases. Available from:  (Accessed on: July 12, 2021)."},{"key":"ref=18","unstructured":"Medscape. Nifurtimox (Rx), drugs and diseases. Available from:  (Accessed on: July 12, 2021)."},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1128\/AAC.03814-14","volume":"59","author":"\u00c1lvarez G.","year":"2015","unstructured":"\u00c1lvarez G.; Varela J.; Cruces E.; Fern\u00e1ndez M.; Gabay M.; Leal S.M.; Escobar P.; Sanabria L.; Serna E.; Torres S.; Figueredo Thiel S.J.; Yaluff G.; Vera de Bilbao N.I.; Cerecetto H.; Gonz\u00e1lez M.; Identification of a new amidecontaining thiazole as a drug candidate for treatment of Chagas\u2019 disease. Antimicrob Agents Chemother 2015,59(3),1398-1404","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.ejmech.2015.06.018","volume":"100","author":"\u00c1lvarez G.","year":"2015","unstructured":"\u00c1lvarez G.; Mart\u00ednez J.; Varela J.; Birriel E.; Cruces E.; Gabay M.; Leal S.M.; Escobar P.; Aguirre-L\u00f3pez B.; Cabrera N.; Tuena de G\u00f3mez-Puyou M.; G\u00f3mez Puyou A.; P\u00e9rez-Montfort R.; Yaluff G.; Torres S.; Serna E.; Vera de Bilbao N.; Gonz\u00e1lez M.; Cerecetto H.; Development of bis-thiazoles as inhibitors of triosephosphate isomerase from Trypanosoma cruzi. Identification of new nonmutagenic agents that are active in vivo. Eur J Med Chem 2015,100,246-256","journal-title":"Eur J Med Chem"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1021\/jm5015742","volume":"58","author":"Papadopoulou M.V.","year":"2015","unstructured":"Papadopoulou M.V.; Bloomer W.D.; Lepesheva G.I.; Rosenzweig H.S.; Kaiser M.; Aguilera-Venegas B.; Wilkinson S.R.; Chatelain E.; Ioset J.R.; Novel 3-nitrotriazolebased amides and carbinols as bifunctional antichagasic agents. J Med Chem 2015,58(3),1307-1319","journal-title":"J Med Chem"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"6467","DOI":"10.1016\/j.bmc.2015.08.014","volume":"23","author":"Papadopoulou M.V.","year":"2015","unstructured":"Papadopoulou M.V.; Bloomer W.D.; Rosenzweig H.S.; O\u2019Shea I.P.; Wilkinson S.R.; Kaiser M.; Chatelain E.; Ioset J.R.; Discovery of potent nitrotriazole-based antitrypanosomal agents: In vitro and in vivo evaluation. Bioorg Med Chem 2015,23(19),6467-6476","journal-title":"Bioorg Med Chem"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.ejmech.2016.08.002","volume":"123","author":"Papadopoulou M.V.","year":"2016","unstructured":"Papadopoulou M.V.; Bloomer W.D.; Rosenzweig H.S.; Wilkinson S.R.; Szular J.; Kaiser M.; Nitrotriazole-based acetamides and propanamides with broad spectrum antitrypanosomal activity. Eur J Med Chem 2016,123,895-904","journal-title":"Eur J Med Chem"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"e02717","DOI":"10.1128\/AAC.02717-16","volume":"61","author":"Papadopoulou M.V.","year":"2017","unstructured":"Papadopoulou M.V.; Bloomer W.D.; Rosenzweig H.S.; Mazzeti A.L.; Gon\u00e7alves K.R.; Mendes P.F.; Bahia M.T.; Nitrotriazole-based compounds as antichagasic agents in a long-treatment in vivo assay. Antimicrob Agents Chemother 2017,61(5),e02717-16","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"7478","DOI":"10.1016\/j.bmc.2015.10.048","volume":"23","author":"de Oliveira Filho G.B.","year":"2015","unstructured":"de Oliveira Filho G.B.; de Oliveira Cardoso M.V.; Esp\u00edndola J.W.P.; Ferreira L.F.G.R.; de Simone C.A.; Ferreira R.S.; Coelho P.L.; Meira C.S.; Magalhaes Moreira D.R.; Soares M.B.P.; Lima Leite; A.C. Structural design, synthesis and pharmacological evaluation of 4-thiazolidinones against Trypanosoma cruzi. Bioorg Med Chem 2015,23(23),7478-7486","journal-title":"Bioorg Med Chem"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.ejmech.2017.09.047","volume":"141","author":"de Oliveira Filho G.B.","year":"2017","unstructured":"de Oliveira Filho G.B.; Cardoso M.V.O.; Esp\u00edndola J.W.P.; Oliveira e Silva D.A.; Ferreira R.S.; Coelho P.L.; Anjos P.S.; Santos E.S.; Meira C.S.; Moreira D.R.M.; Soares M.B.P.; Leite A.C.L.; Leite A.C.L.; Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi. Eur J Med Chem 2017,141(141),346-361","journal-title":"Eur J Med Chem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.ejmech.2014.11.004","volume":"89","author":"Olmo F.","year":"2015","unstructured":"Olmo F.; Guardia J.J.; Marin C.; Messouri I.; Rosales M.J.; Urbanov\u00e1 K.; Chayboun I.; Chahboun R.; Alvarez-Manzaneda E.J.; S\u00e1nchez-Moreno M.; Prospects of an alternative treatment against Trypanosoma cruzi based on abietic acid derivatives show promising results in Balb\/c mouse model. Eur J Med Chem 2015,89(89),683-690","journal-title":"Eur J Med Chem"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ejmech.2015.10.034","volume":"106","author":"Olmo F.","year":"2015","unstructured":"Olmo F.; G\u00f3mez-Contreras F.; Navarro P.; Mar\u00edn C.; Yunta M.J.R.; Cano C.; Campayo L.; Mart\u00edn-Oliva D.; Rosales M.J.; S\u00e1nchez-Moreno M.; Synthesis and evaluation of in vitro and in vivo trypanocidal properties of a new imidazole-containing nitrophthalazine derivative. Eur J Med Chem 2015,106(106),106-119","journal-title":"Eur J Med Chem"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.exppara.2016.02.004","volume":"164","author":"Olmo F.","year":"2016","unstructured":"Olmo F.; Cuss\u00f3 O.; Mar\u00edn C.; Rosales M.J.; Urbanov\u00e1 K.; Krauth-Siegel R.L.; Costas M.; Ribas X.; S\u00e1nchez-Moreno M.; In vitro and in vivo identification of tetradentated polyamine complexes as highly efficient metallodrugs against Trypanosoma cruzi. Exp Parasitol 2016,164,20-30","journal-title":"Exp Parasitol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"10929","DOI":"10.1021\/acs.jmedchem.6b00784","volume":"59","author":"Moreno-Viguri E.","year":"2016","unstructured":"Moreno-Viguri E.; Jim\u00e9nez-Montes C.; Mart\u00edn-Escolano R.; Santiva\u00f1ez-Veliz M.; Martin-Montes A.; Azqueta A.; Jimenez-Lopez M.; Zamora L.S.; Cirauqui N.; L\u00f3pez de Cer\u00e1in A.; Mar\u00edn C.; S\u00e1nchez-Moreno M.; P\u00e9rez-Silanes S.; In vitro and in vivo anti-Trypanosoma cruzi activity of new arylamine mannich base-type derivatives. J Med Chem 2016,59(24),10929-10945","journal-title":"J Med Chem"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"5643","DOI":"10.1021\/acs.jmedchem.8b00468","volume":"61","author":"Mart\u00edn-Escolano R.","year":"2018","unstructured":"Mart\u00edn-Escolano R.; Moreno-Viguri E.; Santiva\u00f1ez-Veliz M.; Martin-Montes A.; Medina-Carmona E.; Paucar R.; Mar\u00edn C.; Azqueta A.; Cirauqui N.; Pey A.L.; P\u00e9rez-Silanes S.; S\u00e1nchez-Moreno M.; Second generation of mannich base-type derivatives with in vivo activity against Trypanosoma cruzi. J Med Chem 2018,61(13),5643-5663","journal-title":"J Med Chem"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"3902","DOI":"10.1016\/j.bmc.2019.07.029","volume":"27","author":"Paucar R.","year":"2019","unstructured":"Paucar R.; Mart\u00edn-Escolano R.; Moreno-Viguri E.; Azqueta A.; Cirauqui N.; Mar\u00edn C.; S\u00e1nchez-Moreno M.; P\u00e9rez-Silanes S.; Rational modification of Mannich basetype derivatives as novel antichagasic compounds: Synthesis, in vitro and in vivo evaluation. Bioorg Med Chem 2019,27(17),3902-3917","journal-title":"Bioorg Med Chem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.micinf.2016.07.007","volume":"18","author":"Martins S.C.","year":"2016","unstructured":"Martins S.C.; Lazarin-Bid\u00f3ia D.; Desoti V.C.; Falzirolli H.; da Silva C.C.; Ueda-Nakamura T.; Silva S.O.; 1,3,4-Thiadiazole derivatives of R-(+)- limonene benzaldehydethiosemicarbazones cause death in Trypanosoma cruzi through oxidative stress. Microbes Infect 2016,18(12),787-797","journal-title":"Microbes Infect"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1128\/AAC.01667-15","volume":"60","author":"Guedes-da-Silva F.H.","year":"2016","unstructured":"Guedes-da-Silva F.H.; Batista D.G.J.; Meuser M.B.; Demarque K.C.; Fulco T.O.; Ara\u00fajo J.S.; Da Silva P.B.; Da Silva C.F.; Patrick D.A.; Bakunova S.M.; Bakunov S.A.; Tidwell R.R.; Oliveira G.M.; Britto C.; Moreira O.C.; Soeiro M.N.C.; In vitro and in vivo trypanosomicidal action of novel arylimidamides against Trypanosoma cruzi. Antimicrob Agents Chemother 2016,60(4),2425-2434","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.2147\/DDDT.S120618","volume":"11","author":"Da Silva C.F.","year":"2017","unstructured":"Da Silva C.F.; Batista D.G.J.; de Ara\u00fajo J.S.; Cunha-Junior E.F.; Stephens C.E.; Banerjee M.; Farahat A.A.; Akay S.; Fisher M.K.; Boykin D.W.; Soeiro M.N.C.; Phenotypic evaluation and in silico ADMET properties of novel arylimidamides in acute mouse models of Trypanosoma cruzi infection. Drug Des Devel Ther 2017,11,1095-1105","journal-title":"Drug Des Devel Ther"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"e02205","DOI":"10.1128\/AAC.02205-17","volume":"62","author":"Santos C.C.","year":"2018","unstructured":"Santos C.C.; Lionel J.R.; Peres R.B.; Batista M.M.; da Silva P.B.; de Oliveira G.M.; da Silva C.F.; Batista D.G.J.; Souza S.M.O.; Andrade C.H.; Neves B.J.; Braga R.C.; Patrick D.A.; Bakunova S.M.; Tidwell R.R.; Soeiro M.N.C.; In vitro, in silico, and in vivo analyses of novel aromatic amidines against Trypanosoma cruzi. Antimicrob Agents Chemother 2018,62(2),e02205-17","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.ejmech.2017.08.055","volume":"139","author":"Tempone A.G.","year":"2017","unstructured":"Tempone A.G.; Ferreira D.D.; Lima M.L.; Costa Silva T.A.; Borborema S.E.T.; Reim\u00e3o J.Q.; Galuppo M.K.; Guerra J.M.; Russell A.J.; Wynne G.M.; Lai R.Y.L.; Cadelis M.M.; Copp B.R.; Efficacy of a series of alphapyrone derivatives against Leishmania infantum (L.) and Trypanosoma cruzi. Eur J Med Chem 2017,139,947-960","journal-title":"Eur J Med Chem"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ejmech.2018.02.020","volume":"149","author":"Ferreira de Almeida Fiuza L.","year":"2018","unstructured":"Ferreira de Almeida Fiuza L.; Peres R.B.; Sim\u00f5es-Silva M.R.; da Silva P.B.; Batista D.G.J.; da Silva C.F.; Nefertiti Silva da Gama A.; Krishna Reddy T.R.; Soeiro M.N.C.; Identification of Pyrazolo[3,4-e][1,4]thiazepin based CYP51 inhibitors as potential Chagas disease therapeutic alternative: In vitro and in vivo evaluation, binding mode prediction and SAR exploration. Eur J Med Chem 2018,149,257-268","journal-title":"Eur J Med Chem"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1016\/j.biopha.2018.09.176","volume":"108","author":"Cunha Almeida T.","year":"2018","unstructured":"Cunha Almeida T.; Gonzaga Ribeiro L.H.; Ferreira dos Santos L.B.; da Silva C.M.; Tupinamb\u00e1 Branquinho R.; de Lana M.; Ramos Gadelha F.; de F\u00e1tima \u00c2.; Synthesis, in vitro and in vivo anti-Trypanosoma cruzi and toxicological activities of nitroaromatic Schiff bases. Biomed Pharmacother 2018,108,1703-1711","journal-title":"Biomed Pharmacother"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1002\/cmdc.201800512","volume":"13","author":"Mart\u00edn-Escolano R.","year":"2018","unstructured":"Mart\u00edn-Escolano R.; Aguilera-Venegas B.; Mar\u00edn C.; Mart\u00edn-Montes \u00c1.; Mart\u00edn-Escolano J.; Medina-Carmona E.; Ar\u00e1n V.J.; S\u00e1nchez-Moreno M.; Synthesis, and biological in vitro and in vivo evaluation of 2-(5-Nitroindazol-1-yl)ethylamine and related compounds as potential therapeutic alternatives for CD. ChemMedChem 2018,13(19),2104-2118","journal-title":"ChemMedChem"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"e01936","DOI":"10.1128\/AAC.01936-17","volume":"62","author":"Nefertiti A.S.G.","year":"2018","unstructured":"Nefertiti A.S.G.; Batista M.M.; Da Silva P.B.; Batista D.G.J.; Da Silva C.F.; Peres R.B.; Torres-Santos E.C.; Cunha-Junior E.F.; Holt E.; Boykin D.W.; Brun R.; Wenzler T.; Soeiro M.N.C.; In vitro and in vivo studies of the trypanocidal effect of novel quinolines. Antimicrob Agents Chemother 2018,62(2),e01936-17","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"111877","DOI":"10.1016\/j.ejmech.2019.111877","volume":"186","author":"Muscia G.C.","year":"2020","unstructured":"Muscia G.C.; Rold\u00e1n Pacheco F.J.; As\u00eds S.E.; Buldain G.Y.; Frank F.M.; Hit-to-lead optimization of novel 2-alkylaminomethylquinoline derivatives as anti-chagas agents. Eur J Med Chem 2020,186,111877","journal-title":"Eur J Med Chem"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"8847","DOI":"10.1021\/acs.jmedchem.9b01275","volume":"62","author":"Lin C.","year":"2019","unstructured":"Lin C.; Hulpia F.; da Silva C.F.; Batista D.G.J.; Van Hecke K.; Maes L.; Caljon G.; Soeiro M.N.C.; Van Calenbergh S.; Discovery of pyrrolo[2,3-b]pyridine (1,7-dideazapurine) nucleoside analogues as anti-Trypanosoma cruzi agents. J Med Chem 2019,62(19),8847-8865","journal-title":"J Med Chem"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"115855","DOI":"10.1016\/j.bmc.2020.115855","volume":"29","author":"Ribeiro J.L.S.","year":"2021","unstructured":"Ribeiro J.L.S.; Soares J.C.A.V.; Portapilla G.B.; Providello M.V.; Lima C.H.S.; Muri E.M.F.; de Albuquerque S.; Dias L.R.S.; Trypanocidal activity of new 1,6-diphenyl-1H-pyrazolo[3,4-b]pyridine derivatives: Synthesis, in vitro and in vivo studies. Bioorg Med Chem 2021,29,115855","journal-title":"Bioorg Med Chem"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"108125","DOI":"10.1016\/j.exppara.2021.108125","volume":"226-227","author":"dos Santos Petry L.","year":"2021","unstructured":"dos Santos Petry L.; Pillar Mayer J.C.; de Giacommeti M.; Teixeira de Oliveira D.; Razia Garzon L.; Martiele Engelmann A.; Magalh\u00e3es de Matos A.F.I.; Dellam\u00e9a Baldissera M.; Dornelles L.; Melazzo de Andrade C.; Gonzalez Monteiro S.; In vitro and in vivo trypanocidal activity of a benzofuroxan derivative against Trypanosoma cruzi. Exp Parasitol 2021,226-227,108125","journal-title":"Exp Parasitol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3390\/molecules26020423","volume":"26","author":"Lara L.S.","year":"2021","unstructured":"Lara L.S.; Lechuga G.C.; Moreira C.S.; Santos T.B.; Ferreira V.F.; da Rocha D.R.; Pereira M.C.S.; Optimization of 1, 4-naphthoquinone hit compound: A computational, phenotypic, and in vivo screening against Trypanosoma cruzi. Molecules 2021,26(2),423","journal-title":"Molecules"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1021\/acsinfecdis.1c00048","volume":"7","author":"Mart\u00edn-Escolano R.","year":"2021","unstructured":"Mart\u00edn-Escolano R.; Etxebeste-Mitxeltorena M.; Mart\u00edn-Escolano J.; Plano D.; Rosales M.J.; Espuelas S.; Moreno E.; S\u00e1nchez-Moreno M.; Carmen S.C.; Mar\u00edn C.; Selenium derivatives as promising therapy for Chagas disease: In vitro and in vivo studies. ACS Infect Dis 2021,7(6),1727-1738","journal-title":"ACS Infect Dis"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"4653","DOI":"10.1128\/AAC.00520-15","volume":"59","author":"Francisco A.F.","year":"2015","unstructured":"Francisco A.F.; Lewis M.D.; Jayawardhana S.; Taylor M.C.; Chatelain E.; Kelly J.M.; Limited ability of posaconazole to cure both acute and chronic Trypanosoma cruzi infections revealed by highly sensitive in vivo imaging. Antimicrob Agents Chemother 2015,59(8),4653-4661","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ijantimicag.2012.03.009","volume":"40","author":"Veiga-Santos P.","year":"2012","unstructured":"Veiga-Santos P.; Barrias E.S.; Santos J.F.C.; de Barros Moreira T.L.; de Carvalho T.M.U.; Urbina J.A.; de Souza W.; Effects of amiodarone and posaconazole on the growth and ultrastructure of Trypanosoma cruzi. Int J Antimicrob Agents 2012,40(1),61-71","journal-title":"Int J Antimicrob Agents"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"e0128707","DOI":"10.1371\/journal.pone.0128707","volume":"10","author":"Martins T.A.F.","year":"2015","unstructured":"Martins T.A.F.; De Figueiredo D.L.; Mazzeti A.L.; Do Nascimento \u00c1.F.D.S.; Caldas S.; Caldas I.S.; Andrade I.M.; Ribeiro I.; Bahia M.T.; Benznidazole\/itraconazole combination treatment enhances anti-Trypanosoma cruzi activity in experimental Chagas Disease. PLoS One 2015,10(6),e0128707","journal-title":"PLoS One"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"3344","DOI":"10.1128\/AAC.05785-11","volume":"56","author":"Moreira da Silva R.","year":"2012","unstructured":"Moreira da Silva R.; Oliveira L.T.; Silva Barcellos N.M.; de Souza J.; de Lana M.; Preclinical monitoring of drug association in experimental chemotherapy of Chagas\u2019 disease by a new HPLC-UV method. Antimicrob Agents Chemother 2012,56(6),3344-3348","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"105606","DOI":"10.1016\/j.actatropica.2020.105606","volume":"211","author":"Gulin J.E.N.","year":"2020","unstructured":"Gulin J.E.N.; Eagleson M.A.; L\u00f3pez-Mu\u00f1oz R.A.; Solana M.E.; Altcheh J.; Garc\u00eda-Bournissen F.; In vitro and in vivo activity of voriconazole and benznidazole combination on Trypanosoma cruzi infection models. Acta Trop 2020,211,105606","journal-title":"Acta Trop"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.exppara.2018.04.016","volume":"189","author":"Strauss M.","year":"2018","unstructured":"Strauss M.; Rodrigues J.H.S.; Lo Presti M.S.; Baz\u00e1n P.C.; B\u00e1ez A.L.; Paglini-Oliva P.; Nakamura C.V.; Bustamante J.M.; Rivarola H.W.; In vitro and in vivo drug combination for the treatment of Trypanosoma cruzi infection: A multivariate approach. Exp Parasitol 2018,189,19-27","journal-title":"Exp Parasitol"},{"key":"ref=54","first-page":"331","volume":"47","author":"Greco W.R.","year":"1995","unstructured":"Greco W.R.; Bravo G.; Parsons J.C.; The search for synergy: A critical review from a response surface perspective. Pharmacol Rev 1995,47(2),331-385","journal-title":"Pharmacol Rev"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"939","DOI":"10.2174\/1389557517666170315145410","volume":"17","author":"V\u00e1zquez K.","year":"2017","unstructured":"V\u00e1zquez K.; Paulino M.; Salas C.O.; Zarate-Ramos J.J.; Vera B.; Rivera G.; Trypanothione reductase: A target for the development of anti-Trypanosoma cruzi drugs. Mini Rev Med Chem 2017,17(11),939-946","journal-title":"Mini Rev Med Chem"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.cbpa.2006.03.004","volume":"146","author":"Maya J.D.","year":"2007","unstructured":"Maya J.D.; Cassels B.K.; Iturriaga-V\u00e1squez P.; Ferreira J.; Fa\u00fandez M.; Galanti N.; Ferreira A.; Morello A.; Mode of action of natural and synthetic drugs against Trypanosoma cruzi and their interaction with the mammalian host. Comp Biochem Physiol A Mol Integr Physiol 2007,146(4),601-620","journal-title":"Comp Biochem Physiol A Mol Integr Physiol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"e0007226","DOI":"10.1371\/journal.pntd.0007226","volume":"13","author":"Santos Souza H.F.","year":"2019","unstructured":"Santos Souza H.F.; Rocha S.C.; Damasceno F.S.; Rapado L.N.; Pral E.M.F.; Marinho C.R.F.; Silber A.M.; The effect of memantine, an antagonist of the NMDA glutamate receptor, in in vitro and in vivo infections by Trypanosoma cruzi. PLoS Negl Trop Dis 2019,13(9),e0007226","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"e2717","DOI":"10.1371\/journal.pntd.0002717","volume":"8","author":"Damasceno F.S.","year":"2014","unstructured":"Damasceno F.S.; Baris\u00f3n M.J.; Pral E.M.F.; Paes L.S.; Silber A.M.; Memantine, an antagonist of the NMDA glutamate receptor, affects cell proliferation, differentiation and the intracellular cycle and induces apoptosis in Trypanosoma cruzi. PLoS Negl Trop Dis 2014,8(2),e2717","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"976","DOI":"10.4269\/ajtmh.15-0237","volume":"93","author":"Penitente A.R.","year":"2015","unstructured":"Penitente A.R.; Shrestha D.; Horta A.L.; Leite A.L.J.; Neves C.A.; Natali A.J.; de Paula Costa G.; Talvani A.; Enalapril in combination with BZN reduces cardiac inflammation and creatine kinases in mice chronically infected with Trypanosoma cruzi. Am J Trop Med Hyg 2015,93(5),976-982","journal-title":"Am J Trop Med Hyg"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.exppara.2015.05.012","volume":"166","author":"da Silva M.T.A.","year":"2016","unstructured":"da Silva M.T.A.; Silva-Jardim I.; Portapilla G.B.; de Lima G.M.A.; Costa F.C.; Anibal F.F.; Thiemann O.H.; In vivo and in vitro auranofin activity against Trypanosoma cruzi: Possible new uses for an old drug. Exp Parasitol 2016,166,189-193","journal-title":"Exp Parasitol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"e1191","DOI":"10.1038\/cddis.2014.132","volume":"5","author":"Fan C.","year":"2014","unstructured":"Fan C.; Zheng W.; Fu X.; Li X.; Wong Y-S.; Chen T.; Enhancement of auranofin-induced lung cancer cell apoptosis by selenocystine, a natural inhibitor of TrxR1 in vitro and in vivo. Cell Death Dis 2014,5(4),e1191","journal-title":"Cell Death Dis"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.bcp.2017.08.025","volume":"141","author":"Silva M.","year":"2017","unstructured":"Silva M.; Ara\u00fajo J.; Oliveira G.; Demarque K.; Peres R.; Melo I.; Batista D.; Silva C.; Santos C.; Silva P.; Batista M.; Bahia M.; Soeiro M.; Strategy for the reuse of drugs against Trypanosoma cruzi infection: In vitro and in vivo evaluation of metronidazole activity in monotherapy and combination therapy. Biochem Pharmacol 2017,141,49-51","journal-title":"Biochem Pharmacol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1039\/C4OB02561J","volume":"13","author":"Kumar T.","year":"2015","unstructured":"Kumar T.; Verma D.; Menna-Barreto R.F.S.; Valen\u00e7a W.O.; da Silva J\u00fanior E.N.; Namboothiri I.N.N.; Synthesis of imidazoles via cascade reaction of nitroallylic acetates with amidines and studies on their trypanocidal activity. Org Biomol Chem 2015,13(7),1996-2000","journal-title":"Org Biomol Chem"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"e0006764","DOI":"10.1371\/journal.pntd.0006764","volume":"12","author":"Puente V.","year":"2018","unstructured":"Puente V.; Demaria A.; Frank F.M.; Batlle A.; Lombardo M.E.; Anti-parasitic effect of vitamin C alone and in combination with benznidazole against Trypanosoma cruzi. PLoS Negl Trop Dis 2018,12(9),e0006764","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/nrd2144","volume":"5","author":"Nwaka S.","year":"2006","unstructured":"Nwaka S.; Hudson A.; Innovative lead discovery strategies for tropical diseases. Nat Rev Drug Discov 2006,5(11),941-955","journal-title":"Nat Rev Drug Discov"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"e02264","DOI":"10.1128\/AAC.02264-18","volume":"63","author":"Mazzeti A.L.","year":"2019","unstructured":"Mazzeti A.L.; Diniz L.F.; Gon\u00e7alves K.R.; WonDollinger, R.S.; Ass\u00edria, T.; Ribeiro, I.; Bahia, M.T. Synergic effect of allopurinol in combination with nitroheterocyclic compounds against Trypanosoma cruzi. Antimicrob Agents Chemother 2019,63(6),e02264-18","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/S0140-6736(18)30324-6","volume":"391","author":"Ashley E.A.","year":"2018","unstructured":"Ashley E.A.; Pyae Phyo A.; Woodrow C.J.; Malaria. Lancet 2018,391(10130),1608-1621","journal-title":"Lancet"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"025569","DOI":"10.1101\/cshperspect.a025569","volume":"8","author":"Milner D.A.J.","year":"2018","unstructured":"Milner D.A.J.; Malaria pathogenesis. Cold Spring Harb Perspect Med 2018,8(1),025569","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref=69","unstructured":"World Health Organization (WHO), Malaria. Available from:  (Accessed on: July 19, 2021)."},{"key":"ref=70","unstructured":"Centers for Disease Control Prevention (CDC). Malaria. Available from:  (Accessed on: July 19, 2021)."},{"key":"ref=71","unstructured":"Medscape. Antimal\u00e1ricos. Available from:  (Accessed on :July 19, 2021)."},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1016\/j.bmcl.2015.04.014","volume":"25","author":"Soares R.R.","year":"2015","unstructured":"Soares R.R.; da Silva J.M.F.; Carlos B.C.; da Fonseca C.C.; de Souza L.S.A.; Lopes F.V.; de Paula Dias R.M.; Moreira P.O.L.; Abramo C.; Viana G.H.R.; de Pila Varotti F.; da Silva A.D.; Scopel K.K.G.; New quinoline derivatives demonstrate a promising antimalarial activity against Plasmodium falciparum in vitro and Plasmodium berghei in vivo. Bioorg Med Chem Lett 2015,25(11),2308-2313","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"673","DOI":"10.3109\/14756360903508430","volume":"25","author":"Ahmed W.","year":"2010","unstructured":"Ahmed W.; Rani M.; Khan I.A.; Iqbal A.; Khan K.M.; Haleem M.A.; Azim M.K.; Characterisation of hydrazides and hydrazine derivatives as novel aspartic protease inhibitors. J Enzyme Inhib Med Chem 2010,25(5),673-678","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"5979","DOI":"10.1016\/j.bmc.2015.06.056","volume":"23","author":"Pinheiro L.C.S.","year":"2015","unstructured":"Pinheiro L.C.S.; Boechat N.; Ferreira M.L.G.; J\u00fanior C.C.S.; Jesus A.M.L.; Leite M.M.M.; Souza N.B.; Krettli A.U.; Anti- Plasmodium falciparum activity of quinoline\u2013sulfonamide hybrids. Bioorg Med Chem 2015,23(17),5979-5984","journal-title":"Bioorg Med Chem"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1021\/jm501809x","volume":"58","author":"Korotchenko V.","year":"2015","unstructured":"Korotchenko V.; Sathunuru R.; Gerena L.; Caridha D.; Li Q.; Kreishman-Deitrick M.; Smith P.L.; Lin A.J.; Antimalarial activity of 4-amidinoquinoline and 10-amidinobenzonaphthyridine derivatives. J Med Chem 2015,58(8),3411-3431","journal-title":"J Med Chem"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"5419","DOI":"10.1016\/j.bmc.2015.07.051","volume":"23","author":"Ongarora D.S.B.","year":"2015","unstructured":"Ongarora D.S.B.; Strydom N.; Wicht K.; Njoroge M.; Wiesner L.; Egan T.J.; Wittlin S.; Jurva U.; Masimirembwa C.M.; Chibale K.; Antimalarial benzoheterocyclic 4-aminoquinolines: Structure\u2013activity relationship, in vivo evaluation, mechanistic and bioactivation studies. Bioorg Med Chem 2015,23(17),5419-5432","journal-title":"Bioorg Med Chem"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.ejmech.2016.06.033","volume":"122","author":"Singh S.","year":"2016","unstructured":"Singh S.; Agarwal D.; Sharma K.; Sharma M.; Nielsen M.A.; Alifrangis M.; Singh A.K.; Gupta R.D.; Awasthi S.K.; 4-Aminoquinoline derivatives: Synthesis, in vitro and in vivo antiplasmodial activity against chloroquine-resistant parasites. Eur J Med Chem 2016,122,394-407","journal-title":"Eur J Med Chem"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.ijpddr.2018.10.002","volume":"8","author":"Aguiar A.C.C.","year":"2018","unstructured":"Aguiar A.C.C.; Murce E.; Cortopassi W.A.; Pimentel A.S.; Almeida M.M.F.S.; Barros D.C.S.; Guedes J.S.; Meneghetti M.R.; Krettli A.U.; Chloroquine analogs as antimalarial candidates with potent in vitro and in vivo activity. Int J Parasitol Drugs Drug Resist 2018,8(3),459-464","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"5547","DOI":"10.1021\/acs.jmedchem.8b00143","volume":"61","author":"Aguiar A.C.C.","year":"2018","unstructured":"Aguiar A.C.C.; Panciera M.; Sim\u00e3o dos Santos E.F.; Singh M.K.; Garcia M.L.; de Souza G.E.; Nakabashi M.; Costa J.L.; Garcia C.R.S.; Oliva G.; Correia C.R.D.; Guido R.V.C.; Discovery of marinoquinolines as potent and Fast-Acting Plasmodium falciparum inhibitors with in vivo activity. J Med Chem 2018,61(13),5547-5568","journal-title":"J Med Chem"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.exppara.2018.01.015","volume":"185","author":"Jain S.","year":"2018","unstructured":"Jain S.; Kumar A.; Saini D.; Novel arylidene derivatives of quinoline based thiazolidinones: Synthesis, in vitro, in vivo and in silico study as antimalarials. Exp Parasitol 2018,185,107-114","journal-title":"Exp Parasitol"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1021\/acsmedchemlett.8b00496","volume":"10","author":"Tripathi M.","year":"2019","unstructured":"Tripathi M.; Taylor D.; Khan S.I.; Tekwani B.L.; Ponnan P.; Das U.S.; Velpandian T.; Rawat D.S.; Hybridization of fluoro-amodiaquine (FAQ) with pyrimidines: Synthesis and antimalarial efficacy of FAQ\u2013Pyrimidines. ACS Med Chem Lett 2019,10(5),714-719","journal-title":"ACS Med Chem Lett"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"221","DOI":"10.4103\/0972-9062.289395","volume":"56","author":"Tahghighi A.","year":"2019","unstructured":"Tahghighi A.; Parhizgar A.; Karimi S.; Irani M.; Synthesis of novel amodiaquine analogs and evaluation of their in vitro and in vivo antimalarial activities. J Vector Borne Dis 2019,56(3),221-230","journal-title":"J Vector Borne Dis"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1186\/s12936-015-1032-5","volume":"14","author":"Dambuza N.S.","year":"2015","unstructured":"Dambuza N.S.; Smith P.; Evans A.; Norman J.; Taylor D.; Andayi A.; Egan T.; Chibale K.; Wiesner L.; Antiplasmodial activity, in vivo pharmacokinetics and antimalarial efficacy evaluation of hydroxypyridinone hybrids in a mouse model. Malar J 2015,14(1),505","journal-title":"Malar J"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"4755","DOI":"10.1016\/j.bmc.2015.05.040","volume":"23","author":"Romero A.H.","year":"2015","unstructured":"Romero A.H.; Acosta M.E.; Gamboa N.; Charris J.E.; Salazar J.; L\u00f3pez S.E.; Synthesis, \u03b2-hematin inhibition studies and antimalarial evaluation of dehydroxy isotebuquine derivatives against Plasmodium berghei. Bioorg Med Chem 2015,23(15),4755-4762","journal-title":"Bioorg Med Chem"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"12984","DOI":"10.1021\/acsomega.0c06053","volume":"6","author":"Tiwari V.S.","year":"2021","unstructured":"Tiwari V.S.; Joshi P.; Yadav K.; Sharma A.; Chowdhury S.; Manhas A.; Kumar N.; Tripathi R.; Haq W.; Synthesis and antimalarial activity of 4-methylaminoquinoline compounds against drug-resistant parasite. ACS Omega 2021,6(20),12984-12994","journal-title":"ACS Omega"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"116018","DOI":"10.1016\/j.bmc.2021.116018","volume":"33","author":"Mizukawa Y.","year":"2021","unstructured":"Mizukawa Y.; Ikegami-Kawai M.; Horiuchi M.; Kaiser M.; Kojima M.; Sakanoue S.; Miyagi S.; Nanga Chick C.; Togashi H.; Tsubuki M.; Ihara M.; Usuki T.; Itoh I.; Quest for a potent antimalarial drug lead: Synthesis and evaluation of 6,7-dimethoxyquinazoline-2,4-diamines. Bioorg Med Chem 2021,33,116018","journal-title":"Bioorg Med Chem"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41421-020-00215-4","volume":"6","author":"Huang Z.","year":"2020","unstructured":"Huang Z.; Li R.; Tang T.; Ling D.; Wang M.; Xu D.; Sun M.; Zheng L.; Zhu F.; Min H.; Boonhok R.; Ding Y.; Wen Y.; Chen Y.; Li X.; Chen Y.; Liu T.; Han J.; Miao J.; Fang Q.; Cao Y.; Tang Y.; Cui J.; Xu W.; Cui L.; Zhu J.; Wong G.; Li J.; Jiang L.; A novel multistage antiplasmodial inhibitor targeting Plasmodium falciparum histone deacetylase 1. Cell Discov 2020,6(1),93","journal-title":"Cell Discov"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1021\/acs.jmedchem.0c02104","volume":"64","author":"Li R.","year":"2021","unstructured":"Li R.; Ling D.; Tang T.; Huang Z.; Wang M.; Ding Y.; Liu T.; Wei H.; Xu W.; Mao F.; Zhu J.; Li X.; Jiang L.; Li J.; Discovery of novel Plasmodium falciparum HDAC1 inhibitors with Dual-Stage antimalarial aotency and improved safety based on the clinical anticancer drug candidate quisinostat. J Med Chem 2021,64(4),2254-2271","journal-title":"J Med Chem"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.ejmech.2016.07.055","volume":"123","author":"Pandey A.K.","year":"2016","unstructured":"Pandey A.K.; Sharma S.; Pandey M.; Alam M.M.; Shaquiquzzaman M.; Akhter M.; 4, 5-Dihydrooxazolepyrazoline hybrids: Synthesis and their evaluation as potential antimalarial agents. Eur J Med Chem 2016,123,476-486","journal-title":"Eur J Med Chem"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"4840","DOI":"10.1021\/acs.jmedchem.7b00008","volume":"60","author":"Schwertz G.","year":"2017","unstructured":"Schwertz G.; Witschel M.C.; Rottmann M.; Bonnert R.; Leartsakulpanich U.; Chitnumsub P.; Jaruwat A.; Ittarat W.; Sch\u00e4fer A.; Aponte R.A.; Charman S.A.; White K.L.; Kundu A.; Sadhukhan S.; Lloyd M.; Freiberg G.M.; Srikumaran M.; Siggel M.; Zwyssig A.; Chaiyen P.; Diederich F.; Antimalarial inhibitors targeting serine hydroxymethyltransferase (SHMT) with in vivo efficacy and analysis of their binding mode based on X-ray cocrystal structures. J Med Chem 2017,60(12),4840-4860","journal-title":"J Med Chem"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.ejmech.2017.04.022","volume":"135","author":"Bhagat S.","year":"2017","unstructured":"Bhagat S.; Arfeen M.; Adane L.; Singh S.; Singh P.P.; Chakraborti A.K.; Bharatam P.V.; Guanylthiourea derivatives as potential antimalarial agents: Synthesis, in vivo and molecular modelling studies. Eur J Med Chem 2017,135,339-348","journal-title":"Eur J Med Chem"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"128305","DOI":"10.1016\/j.bmcl.2021.128305","volume":"49","author":"Shukla M.","year":"2021","unstructured":"Shukla M.; Hassam M.; Kumar Yadav D.; Sharma S.; Singh C.; Puri S.K.; Shrivastava R.; Prakash Verma V.; Synthesis of novel 1,2,4-trioxanes and antimalarial evaluation against multidrug-resistant Plasmodium yoelii nigeriensis. Bioorg Med Chem Lett 2021,49,128305","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1128\/AAC.05012-14","volume":"59","author":"Rocha e Silva L.F.","year":"2015","unstructured":"Rocha e Silva L.F.; Nogueira K.L.; Pinto A.C.S.; Katzin A.M.; Sussmann R.A.C.; Muniz M.P.; Neto V.F.A.; Chaves F.C.M.; Coutinho J.P.; Lima E.S.; Krettli A.U.; Tadei W.P.; Pohlit A.M.; In vivo antimalarial activity and mechanisms of action of 4-nerolidylcatechol derivatives. Antimicrob Agents Chemother 2015,59(6),3271-3280","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3389\/fcimb.2019.00009","volume":"9","author":"El Bissati K.","year":"2019","unstructured":"El Bissati K.; Redel H.; Ting L.M.; Lykins J.D.; McPhillie M.J.; Upadhya R.; Woster P.M.; Yarlett N.; Kim K.; Weiss L.M.; Novel synthetic polyamines have potent antimalarial activities in vitro and in vivo by decreasing intracellular spermidine and spermine concentrations. Front Cell Infect Microbiol 2019,9,9","journal-title":"Front Cell Infect Microbiol"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"e02005","DOI":"10.1128\/AAC.02005-16","volume":"61","author":"Mendes A.M.","year":"2017","unstructured":"Mendes A.M.; Albuquerque I.S.; Machado M.; Pissarra J.; Meireles P.; Prud\u00eancio M.; Inhibition of Plasmodium liver infection by ivermectin. Antimicrob Agents Chemother 2017,61(2),e02005-16","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"e127441","DOI":"10.1172\/jci.insight.127441","volume":"4","author":"Vera I.M.","year":"2019","unstructured":"Vera I.M.; Grilo Ruivo M.T.; Lemos Rocha L.F.; Marques S.; Bhatia S.N.; Mota M.M.; Mancio-Silva L.; Targeting liver stage malaria with metformin. JCI Insight 2019,4(24),e127441","journal-title":"JCI Insight"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"102125","DOI":"10.1016\/j.jddst.2020.102125","volume":"61","author":"Umeyor C.E.","year":"2021","unstructured":"Umeyor C.E.; Okoye I.; Uronnachi E.; Okeke T.; Kenechukwu F.; Attama A.; Repositioning miconazole nitrate for malaria: Formulation of sustained release nanostructured lipid carriers, structure characterization and in vivo antimalarial evaluation. J Drug Deliv Sci Technol 2021,61,102125","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"111275","DOI":"10.1016\/j.biopha.2021.111275","volume":"136","author":"Yadav K.","year":"2021","unstructured":"Yadav K.; Shivahare R.; Shaham S.H.; Joshi P.; Sharma A.; Tripathi R.; Repurposing of existing therapeutics to combat drug-resistant malaria. Biomed Pharmacother 2021,136,111275","journal-title":"Biomed Pharmacother"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.1016\/S1473-3099(16)30475-3","volume":"17","author":"Mutapi F.","year":"2017","unstructured":"Mutapi F.; Maizels R.; Fenwick A.; Woolhouse M.; Human schistosomiasis in the post mass drug administration era. Lancet Infect Dis 2017,17(2),e42-e48","journal-title":"Lancet Infect Dis"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.actatropica.2016.06.024","volume":"164","author":"Barbosa C.S.","year":"2016","unstructured":"Barbosa C.S.; de Souza Gomes E.C.; Campos J.V.; de Oliveira F.J.M.; da Silva Mesquita M.C.; de Oliveira E.C.A.; Domingues A.L.C.; Morbidity of mansoni schistosomiasis in Pernambuco\u2014Brazil: Analysis on the temporal evolution of deaths, hospital admissions and severe clinical forms (1999\u20132014). Acta Trop 2016,164,10-16","journal-title":"Acta Trop"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"e02582","DOI":"10.1128\/AAC.02582-16","volume":"61","author":"Vale N.","year":"2017","unstructured":"Vale N.; Gouveia M.J.; Rinaldi G.; Brindley P.J.; G\u00e4rtner F.; Correia da Costa J.M.; PZQ for schistosomiasis: Single-drug metabolism revisited, mode of action, andresistance. Antimicrob Agents Chemother 2017,61(5),e02582-16","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=102","unstructured":"World Health Organization (WHO). Investing to overcome the global impact of neglected tropical diseases, third WHO report on neglected tropical diseases. 2015. Available from:  (Accessed on: July 19, 2021)."},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"e688","DOI":"10.1016\/S2214-109X(17)30187-0","volume":"5","author":"Coulibaly J.T.","year":"2017","unstructured":"Coulibaly J.T.; Panic G.; Silu\u00e9 K.D.; Kova\u010d J.; Hattendorf J.; Keiser J.; Efficacy and safety of praziquantel in preschool-aged and school-aged children infected with Schistosoma mansoni: A randomised controlled, parallelgroup, dose-ranging, phase 2 trial. Lancet Glob Health 2017,5(7),e688-e698","journal-title":"Lancet Glob Health"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1007\/s00436-012-3151-z","volume":"111","author":"Wang W.","year":"2012","unstructured":"Wang W.; Wang L.; Liang Y.S.; Susceptibility or resistance of praziquantel in human schistosomiasis: A review. Parasitol Res 2012,111(5),1871-1877","journal-title":"Parasitol Res"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.ijpara.2016.03.006","volume":"46","author":"Chevalier F.D.","year":"2016","unstructured":"Chevalier F.D.; Le Clec\u2019h W.; Eng N.; Rugel A.R.; Assis R.R.; Oliveira G.; Holloway S.P.; Cao X.; Hart P.J.; LoVerde P.T.; Anderson T.J.C.; Independent origins of loss-of-function mutations conferring oxamniquine resistance in a Brazilian schistosome population. Int J Parasitol 2016,46(7),417-424","journal-title":"Int J Parasitol"},{"key":"ref=106","first-page":"pp. 467-482","author":"Peter J.H.","year":"2006","unstructured":"Peter J.H.; Donald A.P.B.; Kathleen B.; Simon B.; Lesley D.; Nilanthi S.; Antonio M.; Dirk E.; Matthew J.; Lester C.; Jeffrey C.; Ramanan L.; Catherine M.; Jeff B.; Rodrigo C.O.; Xiao S.; Alan F.; Lorenzo S.; Helminth infections: Soil-transmitted helminth infections and schistosomiasis. In: Disease Control Priorities in Developing Countries, 2nd ed; Dean, T.J.; Joel, G.B.; Anthony, R.M.; George, A.; Mariam, C.; David, B.E.; Prabhat, J.; Anne, M.; Philip, M., Eds.; Oxford University Press and World Bank: Washington, DC, 2006,pp. 467-482"},{"key":"ref=107","doi-asserted-by":"crossref","first-page":"e1007881","DOI":"10.1371\/journal.ppat.1007881","volume":"15","author":"Fr\u00e9d\u00e9ric D.C.","year":"2019","unstructured":"Fr\u00e9d\u00e9ric D.C.; Winka L.C.; Marina M.; Vinay M.; Meghan A.G.; Stephen P.H.; Xiaohang C.; Alexander B.T.; Safari K.; Anouk N.G.; Bonnie L.W.; Joanne P.W.; Aidan M.E.; David R.; Oxamniquine resistance alleles are widespread in old world Schistosoma mansoni and predate drug deployment. PLoS Pathog 2019,15(10),e1007881","journal-title":"PLoS Pathog"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1128\/AAC.04463-14","volume":"59","author":"Cowan N.","year":"2015","unstructured":"Cowan N.; D\u00e4twyler P.; Ernst B.; Wang C.; Vennerstrom J.L.; Spangenberg T.; Keiser J.; Activities of N,N\u2032-Diarylurea MMV665852 analogs against Schistosoma mansoni. Antimicrob Agents Chemother 2015,59(4),1935-1941","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.bmcl.2017.12.064","volume":"28","author":"Wu J.","year":"2018","unstructured":"Wu J.; Wang C.; Leas D.; Vargas M.; White K.L.; Shackleford D.M.; Chen G.; Sanford A.G.; Hemsley R.M.; Davis P.H.; Dong Y.; Charman S.A.; Keiser J.; Vennerstrom J.L.; Progress in antischistosomal N,N\u2032-diaryl urea SAR. Bioorg Med Chem Lett 2018,28(3),244-248","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1039\/C7MD00590C","volume":"9","author":"Zhou S.","year":"2018","unstructured":"Zhou S.; Huang G.; Design, synthesis and bioactivities of phenithionate analogues or derivatives for antischistosomiasis. MedChemComm 2018,9(2),328-336","journal-title":"MedChemComm"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"107933","DOI":"10.1016\/j.exppara.2020.107933","volume":"215","author":"Taman A.","year":"2020","unstructured":"Taman A.; Alhusseiny S.M.; El-Zayady W.M.; Elblihy A.A.; Mansour B.; Massoud M.; Youssef M.Y.; Saleh N.E.; In vivo studies of the effect of PPQ-6, a quinolinebased agent against Schistosoma mansoni in mice. Exp Parasitol 2020,215,107933","journal-title":"Exp Parasitol"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"105236","DOI":"10.1016\/j.ejps.2020.105236","volume":"146","author":"Filho C.A.L.M.","year":"2020","unstructured":"Filho C.A.L.M.; Barbosa M.O.; Oliveira A.R.; Santiago E.F.; de Souza V.C.A.; Lucena J.P.; Fernandes C.J.B.; Santos I.R.; Le\u00e3o R.L.C.; Santos F.A.B.; Alves L.C.; Pereira V.R.A.; de Ara\u00fajo R.E.; Leite A.C.L.; de Oliveira S.A.; In vitro and in vivo activities of multi-target phtalimido-thiazoles on Schistosomiasis mansoni. Eur J Pharm Sci 2020,146,105236","journal-title":"Eur J Pharm Sci"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"5331","DOI":"10.1128\/AAC.00778-16","volume":"60","author":"Khan M.O.F.","year":"2016","unstructured":"Khan M.O.F.; Keiser J.; Amoyaw P.N.A.; Hossain M.F.; Vargas M.; Le J.G.; Simpson N.C.; Roewe K.D.; Freeman T.N.C.; Hasley T.R.; Maples R.D.; Archibald S.J.; Hubin T.J.; Discovery of antischistosomal drug leads based on tetraazamacrocyclic derivatives and their metal complexes. Antimicrob Agents Chemother 2016,60(9),5331-5336","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1021\/acsinfecdis.7b00054","volume":"3","author":"Hess J.","year":"2017","unstructured":"Hess J.; Panic G.; Patra M.; Mastrobuoni L.; Spingler B.; Roy S.; Keiser J.; Gasser G.; Ferrocenyl, ruthenocenyl, and benzyl oxamniquine derivatives with cross-species activity against Schistosoma mansoni and Schistosoma haematobium. ACS Infect Dis 2017,3(9),645-652","journal-title":"ACS Infect Dis"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1039\/C8MD00396C","volume":"9","author":"d\u2019Orchymont F.","year":"2018","unstructured":"d\u2019Orchymont F.; Hess J.; Panic G.; Jakubaszek M.; Gemperle L.; Keiser J.; Gasser G.; Synthesis, characterization and biological activity of organometallic derivatives of the antimalarial drug mefloquine as new antischistosomal drug candidates. MedChemComm 2018,9(11),1905-1909","journal-title":"MedChemComm"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ijpddr.2017.05.002","volume":"7","author":"Gold D.","year":"2017","unstructured":"Gold D.; Alian M.; Domb A.; Karawani Y.; Jbarien M.; Chollet J.; Haynes R.K.; Wong H.N.; Buchholz V.; Greiner A.; Golenser J.; Elimination of Schistosoma mansoni in infected mice by slow release of artemisone. Int J Parasitol Drugs Drug Resist 2017,7(2),241-247","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00436-018-6188-9","volume":"118","author":"Corr\u00eaa S.A.P.","year":"2019","unstructured":"Corr\u00eaa S.A.P.; de Oliveira R.N.; Mendes T.M.F.; dos Santos K.R.; Boaventura S.; Garcia V.L.; Jeraldo V.L.S.; Allegretti S.M.; In vitro and in vivo evaluation of six artemisinin derivatives against Schistosoma mansoni. Parasitol Res 2019,118(2),505-516","journal-title":"Parasitol Res"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s13071-019-3442-7","volume":"12","author":"Wang X.","year":"2019","unstructured":"Wang X.; Yu D.; Li C.; Zhan T.; Zhang T.; Ma H.; Xu J.; Xia C.; In vitro and in vivo activities of DW-3-15, a commercial praziquantel derivative, against Schistosoma japonicum. Parasit Vectors 2019,12(1),199","journal-title":"Parasit Vectors"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"e0003962","DOI":"10.1371\/journal.pntd.0003962","volume":"9","author":"Panic G.","year":"2015","unstructured":"Panic G.; Vargas M.; Scandale I.; Keiser J.; Activity Profile of an FDA-Approved Compound Library against Schistosoma mansoni. PLoS Negl Trop Dis 2015,9(7),e0003962","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1186\/s13071-015-1023-y","volume":"8","author":"Cowan N.","year":"2015","unstructured":"Cowan N.; Keiser J.; Repurposing of anticancer drugs: In vitro and in vivo activities against Schistosoma mansoni. Parasit Vectors 2015,8(1),417","journal-title":"Parasit Vectors"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.actatropica.2014.12.005","volume":"143","author":"Mossallam S.F.","year":"2015","unstructured":"Mossallam S.F.; Amer E.I.; El-Faham M.H.; Efficacy of Synriam\u2122, a new antimalarial combination of OZ277 and piperaquine, against different developmental stages of Schistosoma mansoni. Acta Trop 2015,143,36-46","journal-title":"Acta Trop"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"e0004928","DOI":"10.1371\/journal.pntd.0004928","volume":"10","author":"Guidi A.","year":"2016","unstructured":"Guidi A.; Lalli C.; Perlas E.; Bolasco G.; Nibbio M.; Monteagudo E.; Bresciani A.; Ruberti G.; Discovery and characterization of novel anti-schistosomal properties of the anti-anginal drug, perhexiline and its impact on Schistosoma mansoni male and female reproductive systems. PLoS Negl Trop Dis 2016,10(8),e0004928","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.actatropica.2016.11.006","volume":"166","author":"Eissa M.M.","year":"2017","unstructured":"Eissa M.M.; Mossallam S.F.; Amer E.I.; Younis L.K.; Rashed H.A.; Repositioning of chlorambucil as a potential anti-schistosomal agent. Acta Trop 2017,166,58-66","journal-title":"Acta Trop"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"e01722","DOI":"10.1128\/AAC.01722-18","volume":"63","author":"Guerra R.A.","year":"2018","unstructured":"Guerra R.A.; Silva M.P.; Silva T.C.; Salvadori M.C.; Teixeira F.S.; De Oliveira R.N.; Rocha J.A.; Pinto P.L.S.; De Moraes J.; Spironolactone as an antischistosomal drug capable of clinical repurposing: In vitro and in vivo studies. Antimicrob Agents Chemother 2018,63(3),e01722-e18","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"e01208","DOI":"10.1128\/AAC.01208-19","volume":"63","author":"Roquini D.B.","year":"2019","unstructured":"Roquini D.B.; Cogo R.M.; Mengarda A.C.; Mazloum S.F.; Morais C.S.; Xavier R.P.; Salvadori M.C.; Teixeira F.S.; Ferreira L.E.; Pinto P.L.; Morais T.R.; de Moraes J.; Promethazine exhibits antiparasitic properties in vitro and reduces worm burden, egg production, hepato-, and splenomegaly in a schistosomiasis animal model. Antimicrob Agents Chemother 2019,63(12),e01208-19","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.ebiom.2019.04.029","volume":"43","author":"Lago E.M.","year":"2019","unstructured":"Lago E.M.; Silva M.P.; Queiroz T.G.; Mazloum S.F.; Rodrigues V.C.; Carna\u00faba P.U.; Pinto P.L.; Rocha J.A.; Ferreira L.L.G.; Andricopulo A.D.; de Moraes J.; Phenotypic screening of nonsteroidal anti-inflammatory drugs identified mefenamic acid as a drug for the treatment of schistosomiasis. EBioMedicine 2019,43,370-379","journal-title":"EBioMedicine"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s00436-019-06259-0","volume":"118","author":"Oliveira R.N.","year":"2019","unstructured":"Oliveira R.N.; Corr\u00eaa S.A.P.; Vieira K.M.; Mendes T.; Allegretti S.M.; Miguel D.C.; In vitro schistosomicidal activity of tamoxifen and its effectiveness in a murine model of schistosomiasis at a single dose. Parasitol Res 2019,118(5),1625-1631","journal-title":"Parasitol Res"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"e01372","DOI":"10.1128\/AAC.01372-20","volume":"64","author":"de Brito M.G.","year":"2020","unstructured":"de Brito M.G.; Mengarda A.C.; Oliveira G.L.; Cirino M.E.; Silva T.C.; de Oliveira R.N.; Allegretti S.M.; de Moraes J.; Therapeutic effect of diminazene aceturate on parasitic blood fluke Schistosoma mansoni infection. Antimicrob Agents Chemother 2020,64(11),e01372-20","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"105891","DOI":"10.1016\/j.actatropica.2021.105891","volume":"218","author":"Abou-El-Naga I.F.","year":"2021","unstructured":"Abou-El-Naga I.F.; El-Temsahy M.M.; Mogahed N.M.F.H.; Sheta E.; Makled S.; Ibrahim E.I.; Effect of celecoxib against different developmental stages of experimental Schistosoma mansoni infection. Acta Trop 2021,218,105891","journal-title":"Acta Trop"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867329666220930112136","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/209373\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867329666220930112136","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T19:59:40Z","timestamp":1693684780000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/209373\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":129,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867329666220930112136","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-04-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-29","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}